Deal struck for vector drug delivery to treat ALS
ALS Therapy Development Institute (ALS TDI) and Asklepios BioPharmaceutical have entered into a collaboration to develop viral vectors for drug delivery.
Archives for January 26, 2009
Neuland sets out its stall in peptides
Indian company Neuland Laboratories has launched a push into the peptide manufacturing sector to expand the range of active pharmaceutical ingredients (APIs) it can offer to customers.
Pfizer to acquire Wyeth in $68bn deal
Pfizer has confirmed it has entered into an agreement to buy Wyeth in a deal worth $68bn, which it hopes will strengthen its position in anticipation of a challenging few years.
Rem gets into bed with PsyPharma for sleep studies
Two US companies specialising in sleep disorders - Rem Medical and PsyPharma Global, have pooled their resources to offer research services to the pharmaceutical industry.
Formulation developed to stop vaccine freeze damage
Health charity PATH has developed a formulation to stop vaccines suffering from freeze damage, which it believes will help ensure products are fully potent when they reach their destination.
NAF & VSM look to clean up in pre-washed vial market
We spoke with Martijn Eijkenboom, president of NAF & VSM, to discuss his companies’ entry into the market for pre-washed vials, ampoules and test tubes.